When hormones shift, the body responds.

The closest thing this field has to a canonical site. Therapist-led, research-backed, cited in NICE consultations. Covers queer, trans, non-binary and intersex experiences of menopause without flattening them into one story.

The curated shelf inside Queer Menopause: books, articles, podcasts, first-person pieces and practitioner directories for LGBTQIA+ readers. Kept more current than any single review or clinic page.

The project behind the book: research notes, first-person accounts, one-to-one coaching, and IAOTH-accredited training for providers, doulas and coaches. The clearest place to watch gender-affirming midlife care being built rather than just described.

The full-length version, out Jan 13, 2026 from North Atlantic Books: 256 pages of prompts, self-advocacy scripts for medical settings, and lifestyle and prescription options set side by side, written for trans, gender-nonconforming, genderfluid and queer-bodied readers. Foreword by Marie Benkley. Listed at the publisher's page; any bookseller can order it.

IAOTH-accredited training and certification in gender-affirming menopause care, for providers, doulas and coaches. Small cohorts (15 seats for the Fall 2026 cohort), MD, DNP and PhD guest faculty, and a certified provider directory graduates can be listed in. Useful two ways: search the directory for someone already trained, or hand the course to a clinic that wants to get this right.

The plain-language companion for people weighing the surgery themselves: what each ovary choice can mean for hormones, bone and heart health down the line, and the questions worth asking before consent. Free to read and share.

A free PDF written for clinicians offering gender-affirming hysterectomy and oophorectomy: what menopause-informed consent covers before surgery, including hormone planning, bone health and what changes when the ovaries go. Free to share, and worth handing to a surgical team that hasn't thought this through yet.

Clinician-reviewed plain-language guide written for trans readers. Covers both the estrogen-drop story and the still-have-ovaries story on one page, with practical advice on finding affirming care.

Expert-reviewed explainer with clean terminology and a useful breakdown of which scenarios produce which symptoms. Good for sharing with a doctor who needs the primer.

Newer (2026) split-format piece that does the transmasc and transfemme stories side by side. Particularly good on the testosterone-and-aging-ovaries scenario, which most other guides skim.

Dr. Tami Rowen is a gynecologist who works across menopause and trans health. The episode is the clearest hour we've found on what testosterone actually does in midlife — for cis and trans patients both.

Conversation with a trans woman about what menopause-shaped symptoms look like from the inside, including the workplace angle. Warm and specific.

One of very few episodes anywhere on the transmasculine experience of midlife hormone shifts. Tate Smith is a trans man and educator; the conversation is plain, kind, and useful.

Useful primer on how gender and hormone history change the midlife picture, aimed at a general audience. Good first listen before the more specialized episodes above.

Co-authored by Lasara Firefox Allen, this is a practice-level guide for clinicians: how menopause presents in trans men and gender-diverse people assigned female at birth, what long-term testosterone does and doesn't mask, dosing comparisons across gender-affirming and menopause hormone therapy, and the emotional and relational terrain that usually gets left out. Useful to hand a practitioner who wants to get this right.

The reference endocrinology guideline for long-term estrogen and testosterone therapy in trans patients. The midlife section is thin (acknowledged in the document itself) but it's the standard practitioners are working from.

Cardiovascular risk on long-term estrogen and testosterone — directly relevant to the midlife conversation about HRT continuation, cholesterol and blood pressure.

The current best summary of what the literature does and doesn't say about menopause in trans and gender-diverse people. Honest about the gaps.

Curated list of peer-reviewed papers, qualitative studies and grey literature on LGBTQIA+ menopause — kept more current than any single review article.

After roughly a year on testosterone, AMH and antral follicle count (the standard markers of ovarian reserve) stayed fairly preserved. The modest decline observed was mostly driven by patients who already had PCOS before starting T, not by testosterone itself. Small study, short follow-up — the best current picture, not a settled one.

124 patients who had hysterectomy with bilateral oophorectomy as gender-affirming surgery. Mean age 28.5, range 18 to 43. Surgical menopause in this community starts young.

Of transgender and gender-diverse patients aged 18 to 30 who had gender-affirming hysterectomy, 68% chose to also have both ovaries removed at the same time. More common among those with a male gender identity and those already on testosterone.

Histological changes in ovarian tissue correlated with chronological age, not with duration of testosterone therapy. Supports the picture that ovaries age on their own clock regardless of T. Small sample, single-centre.